Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
59.53 USD | -0.65% | -4.14% | -28.70% |
17/05 | Cytokinetics, Incorporated Announces Resignation of Sandford D. Smith as Board of Directors | CI |
15/05 | Transcript : Cytokinetics, Incorporated - Shareholder/Analyst Call |
Sales 2024 * | 10.53M 877M | Sales 2025 * | 75.12M 6.25B | Capitalization | 6.24B 520B |
---|---|---|---|---|---|
Net income 2024 * | -489M -40.71B | Net income 2025 * | -471M -39.22B | EV / Sales 2024 * | 589 x |
Net cash position 2024 * | 33.92M 2.82B | Net cash position 2025 * | 417M 34.68B | EV / Sales 2025 * | 77.5 x |
P/E ratio 2024 * |
-12.6
x | P/E ratio 2025 * |
-13.9
x | Employees | 423 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.45% |
Latest transcript on Cytokinetics, Incorporated
1 day | -0.65% | ||
1 week | -4.14% | ||
Current month | -2.92% | ||
1 month | -12.37% | ||
3 months | -22.58% | ||
6 months | +83.51% | ||
Current year | -28.70% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 60 | 01/98/01 |
Kari Loeser
CMP | Compliance Officer | - | 01/21/01 |
Stuart Kupfer
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy Wysenski
BRD | Director/Board Member | 66 | 20/20/20 |
Edward Kaye
BRD | Director/Board Member | 75 | 20/16/20 |
Santo Costa
BRD | Director/Board Member | 78 | 01/10/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 0 M€ | 0.00% | - | |
0.39% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 59.53 | -0.65% | 1,056,744 |
16/24/16 | 59.92 | -0.96% | 888,757 |
15/24/15 | 60.5 | +1.92% | 1,267,465 |
14/24/14 | 59.36 | +2.54% | 2,413,912 |
13/24/13 | 57.89 | -6.78% | 3,552,193 |
Delayed Quote Nasdaq, May 18, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.70% | 6.24B | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- CYTK Stock